EMD HEALTHCARE
Live / Applied — New application — not yet assigned to an examiner (as of 30 Jul 2026)
What this means for you
Not registered yet, but its 19 May 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79455124
- Mark type
- Stylized text
- Filed
- 19 May 2026
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations; sanitary preparations for medical purposes; dietary food and substances adapted for medical use; pharmaceutical preparations for the treatment of diseases and disorders in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases; pharmaceutical preparations for the treatment of tumors, neurofibromatosis, multiple myeloma; prefilled syringes containing choriogonadotropin alfa; prefilled syringes containing follitropin alfa; prefilled syringes containing lutropin alfa; prefilled syringes containing interferon beta-1 a; prefilled syringes containing cetrorelix; small molecule therapeutic preparations for the treatment of tumors, cancer, rare diseases, neurofibromatosis, multiple myelom, and diseases in the oncological and neuro-oncological fields.
- Class 009 — Scientific and electric apparatus: Downloadable software applications for mobile devices in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma; downloadable software applications for mobile applications that enable users to access medical and pharmaceutical information in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma.
- Class 010 — Medical apparatus: Medical apparatus, instruments and equipment; medical apparatus, instruments and equipment, namely, injection devices for pharmaceuticals; syringes for medical purposes; hypodermic syringes; needles for injections.
- Class 035 — Advertising and business services: Business management and consultation services in the medical and pharmaceutical field; conducting business conferences in the medical and pharmaceutical field.
- Class 041 — Education and entertainment services: Educational services; providing of training; educational services, namely, conducting training, conferences and workshops in the medical and pharmaceutical fields; providing training about the administration of drugs; conducting educational conferences and workshops in the medical and pharmaceutical fields; providing educational information in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma.
- Class 042 — Scientific and technological services: Scientific and technological services; scientific and technological services, namely research and development in the medical and pharmaceutical field; providing online non-downloadable software for medical and pharmaceutical applications in the pharmaceutical fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma.
- Class 044 — Medical, beauty and agricultural services: Providing medical information, consultancy and advisory services; providing medical and pharmaceutical patient support services in the nature of disease management information, treatment options, and medical advice in the fields of cardiovascular medicine, neurology, immunology, metabolic endocrinology, infertility, oncology, immuno-oncology, neuro-oncology, rare diseases, tumors, neurofibromatosis, multiple myeloma; providing pharmaceutical information about drug treatments and therapeutic properties.
Owner
- Merck KGaA, DE
Prosecution history
- 10 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 10 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Jul 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB